CD103+CD11c+ DCs also outnumbered CD8α+CD11c+ DCs in tumor tissues of DEXP&A2&N-treated orthotopic HCC mice (Fig. 2d, e), indicating the stronger capacity of CD103+CD11c+ DCs to internalize and cross-present cellular neoantigens. The gene discussed is ITGAX; the disease is hepatocellular carcinoma.